Nigel Dunglison
Papers
4
Total Citations
1,196
H-Index
4
About
Nigel Dunglison is a leading urological surgeon whose research has fundamentally shaped the evidence base for treating localised prostate cancer. His primary focus lies in comparing the efficacy and outcomes of robot-assisted laparoscopic prostatectomy (RALP) versus traditional open radical retropubic prostatectomy. Dunglison’s landmark contributions include conducting one of the first randomised controlled phase 3 studies in this field, with his 2016 paper (692 citations) providing critical early outcome data. He followed this with a pivotal 24-month outcomes analysis in 2018 (458 citations), offering robust, long-term comparative evidence on recovery and oncological control. His earlier work, including a 2012 randomised trial (27 citations) and a 2013 progress report (19 citations), laid the groundwork for these larger studies. Collectively, his research has helped surgeons and patients make more informed decisions by clarifying the real-world benefits and limitations of robotic surgery, influencing clinical guidelines worldwide. Dunglison’s dedication to rigorous, prospective trials has made him a key figure in advancing surgical oncology for prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4